Class IIOngoingD-0537-2020
Drug recall · December 11, 2019
Regular Strength Zantac 150 mg recall
Why: CGMP Deviations: Presence of NDMA impurity detected in product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Regular Strength Zantac 150 mg Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 05269-220-25.
- Lots / codes
all lots
- Company
- Sanofi-Aventis U.S. LLC, Bridgewater, NJ
- Distribution
- Nationwide
- Initiated
- October 22, 2019 · Voluntary: Firm initiated
- Classified
- December 1, 2019
- Reported
- December 11, 2019
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingDec 11, 2019Cool Mint Tablets Maximum Strength Zantac 150 mg SanofiSanofi-Aventis U.S. LLC · D-0534-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 75 mgSanofi-Aventis U.S. LLC · D-0535-2020Class IIOngoingDec 11, 2019Maximum Strength Zantac 150 mgSanofi-Aventis U.S. LLC · D-0536-2020Class IIOngoingDec 11, 2019Cool Mint Maximum Strength Zantac 150 mgSanofi-Aventis U.S. LLC · D-0538-2020Class IIOngoingDec 11, 2019Maximum Strength Zantac 150 mgSanofi-Aventis U.S. LLC · D-0539-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 75 mgSanofi-Aventis U.S. LLC · D-0540-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 150 mgSanofi-Aventis U.S. LLC · D-0541-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 75 mgSanofi-Aventis U.S. LLC · D-0542-2020Class IIOngoingDec 11, 2019Regular Strength Zantac 75 mgSanofi-Aventis U.S. LLC · D-0543-2020Class IIOngoingDec 11, 2019Zantac 150 mgSanofi-Aventis U.S. LLC · D-0544-2020Class IIOngoingDec 11, 2019Zantac 75 mgSanofi-Aventis U.S. LLC · D-0545-2020
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.